0
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Anisodamine Hydrobromide ameliorates acute lung injury via inhibiting pyroptosis in murine sepsis model

, , , , &
Received 07 Nov 2023, Accepted 22 Jul 2024, Accepted author version posted online: 29 Jul 2024
Accepted author version

Reference:

  • Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801-810.
  • Rudd KE, Johnson SC, Agesa KM, et al. Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study. Lancet. 2020 Jan 18;395(10219):200-211.
  • Fleischmann C, Scherag A, Adhikari NKJ, et al. Assessment of Global Incidence and Mortality of Hospital-treated Sepsis. Current Estimates and Limitations. Am J Respir Crit Care Med. 2016;193(3):259-272.
  • Kumar V. Pulmonary Innate Immune Response Determines the Outcome of Inflammation During Pneumonia and Sepsis-Associated Acute Lung Injury. Front Immunol. 2020;11:1722.
  • Lagu T, Rothberg MB, Shieh MS, et al. Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007. Crit Care Med. 2012 Mar;40(3):754-61.
  • Park I, Kim M, Choe K, et al. Neutrophils disturb pulmonary microcirculation in sepsis-induced acute lung injury. The European Respiratory Journal. 2019;53(3).
  • Meyer NJ, Gattinoni L, Calfee CS. Acute respiratory distress syndrome. Lancet. 2021 Aug 14;398(10300):622-637.
  • Shi X, Li T, Liu Y, et al. HSF1 Protects Sepsis-Induced Acute Lung Injury by Inhibiting NLRP3 Inflammasome Activation. Frontiers In Immunology. 2022;13:781003.
  • Liu B, Wang Z, He R, et al. Buformin alleviates sepsis-induced acute lung injury via inhibiting NLRP3-mediated pyroptosis through an AMPK-dependent pathway. Clinical Science. 2022;136(4):273-289.
  • Jiang R, Xu J, Zhang Y, et al. Ligustrazine Alleviate Acute Lung Injury Through Suppressing Pyroptosis and Apoptosis of Alveolar Macrophages. Front Pharmacol. 2021;12:680512.
  • Li Z-F, Wang Y-C, Feng Q-R, et al. Inhibition of the C3a receptor attenuates sepsis-induced acute lung injury by suppressing pyroptosis of the pulmonary vascular endothelial cells. Free Radic Biol Med. 2022;184:208-217.
  • Liu Y, Zhang Y, Feng Q, et al. GPA Peptide Attenuates Sepsis-Induced Acute Lung Injury in Mice via Inhibiting Oxidative Stress and Pyroptosis of Alveolar Macrophage. Oxid Med Cell Longev. 2021;2021:5589472.
  • He G, Chen K, Wang H, et al. Fudosteine attenuates acute lung injury in septic mice by inhibiting pyroptosis via the TXNIP/NLRP3/GSDMD pathway. European Journal of Pharmacology. 2022 2022/07/05/;926:175047.
  • Wang YC, Liu QX, Zheng Q, et al. Dihydromyricetin Alleviates Sepsis-Induced Acute Lung Injury through Inhibiting NLRP3 Inflammasome-Dependent Pyroptosis in Mice Model. Inflammation. 2019 Aug;42(4):1301-1310.
  • Su J, Liu Z, Liu C, et al. Network Pharmacology Integrated Molecular Docking Reveals the Mechanism of Anisodamine Hydrobromide Injection against Novel Coronavirus Pneumonia. Evid Based Complement Alternat Med. 2020;2020:5818107.
  • Poupko JM, Baskin SI, Moore E. The pharmacological properties of anisodamine. J Appl Toxicol. 2007 Mar-Apr;27(2):116-21.
  • Yang G-d. [Patients of severe acute respiratory syndrome with hypoxemia treated by anisodamine]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2003;15(8):452.
  • Zhang Y, Song D, Peng Z, et al. Anisodamine Enhances Macrophage M2 Polarization through Suppressing G9a-Mediated Interferon Regulatory Factor 4 Silencing to Alleviate Lipopolysaccharide-Induced Acute Lung Injury. J Pharmacol Exp Ther. 2022 Jun;381(3):247-256.
  • Yuan X, Zheng Y, Chen C, et al. Anisodamine inhibits endoplasmic reticulum stress-associated TXNIP/NLRP3 inflammasome activation in rhabdomyolysis-induced acute kidney injury. Apoptosis. 2017;22(12):1524-1531.
  • Rittirsch D, Huber-Lang MS, Flierl MA, et al. Immunodesign of experimental sepsis by cecal ligation and puncture. Nat Protoc. 2009;4(1):31-36.
  • Wan F, Du X, Liu H, et al. Protective effect of anisodamine hydrobromide on lipopolysaccharide-induced acute kidney injury. Biosci Rep. 2020 Jul 31;40(7).
  • Wang Y, Chen Q, Jiao F, et al. Histone deacetylase 2 regulates ULK1 mediated pyroptosis during acute liver failure by the K68 acetylation site. Cell Death Dis. 2021 Jan 11;12(1):55.
  • Zou Y, Luo X, Feng Y, et al. Luteolin prevents THP-1 macrophage pyroptosis by suppressing ROS production via Nrf2 activation. Chemico-Biological Interactions. 2021;345.
  • Matute-Bello G, Downey G, Moore BB, et al. An Official American Thoracic Society Workshop Report: Features and Measurements of Experimental Acute Lung Injury in Animals. American Journal of Respiratory Cell and Molecular Biology. 2011;44(5):725-738.
  • Du X, Liu H, Yue Y, et al. Anisodamine Hydrobromide Protects Glycocalyx and Against the Lipopolysaccharide-Induced Increases in Microvascular Endothelial Layer Permeability and Nitric Oxide Production. Cardiovascular Engineering and Technology. 2020;12(1):91-100.
  • Auriemma CL, Zhuo H, Delucchi K, et al. Acute respiratory distress syndrome-attributable mortality in critically ill patients with sepsis. Intensive Care Med. 2020;46(6):1222-1231.
  • Zheng Q, Wang Y-C, Liu Q-X, et al. FK866 attenuates sepsis-induced acute lung injury through c-jun-N-terminal kinase (JNK)-dependent autophagy. Life Sci. 2020;250:117551.
  • Luo D, Dai W, Feng X, et al. Suppression of lncRNA NLRP3 inhibits NLRP3-triggered inflammatory responses in early acute lung injury. Cell Death & Disease. 2021;12(10):898.
  • Matthay MA, Zemans RL, Zimmerman GA, et al. Acute respiratory distress syndrome. Nat Rev Dis Primers. 2019;5(1):18.
  • Eskandarian Boroujeni M, Sekrecka A, Antonczyk A, et al. Dysregulated Interferon Response and Immune Hyperactivation in Severe COVID-19: Targeting STATs as a Novel Therapeutic Strategy. Frontiers In Immunology. 2022;13:888897.
  • Qiu Y, Ouyang Z, Zhong J, et al. Anisodamine hydrobromide attenuates oxidative stress and proinflammatory cytokines in septic rats induced by cecal ligation and puncture. Cell Mol Biol (Noisy-le-grand). 2022;68(12):54-60.
  • Di A, Xiong S, Ye Z, et al. The TWIK2 Potassium Efflux Channel in Macrophages Mediates NLRP3 Inflammasome-Induced Inflammation. Immunity. 2018;49(1).
  • Evavold CL, Kagan JC. Inflammasomes: Threat-Assessment Organelles of the Innate Immune System. Immunity. 2019;51(4):609-624.
  • Ding P, Yang R, Li C, et al. Fibroblast growth factor 21 attenuates ventilator-induced lung injury by inhibiting the NLRP3/caspase-1/GSDMD pyroptotic pathway. Critical Care. 2023;27(1).
  • Zeng J, Liu J, Huang J-H, et al. Aloperine alleviates lipopolysaccharide-induced acute lung injury by inhibiting NLRP3 inflammasome activation. International Immunopharmacology. 2023;120.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.